Genistein inhibits angiogenesis developed during rheumatoid arthritis through the IL-6/JAK2/STAT3/VEGF signalling pathway
Authors:
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 22, 92-100
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (NSFC81672224)
- National Natural Science Foundation of China (NSFC81473709)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20180302150101316)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20170818153602439)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20160531174005444)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20170818164059405)
- National Key Research and Development Program of China (2018YFC1705205)
- Development and Reform Commission of Shenzhen Municipality (561)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201808072)
This publication has 36 references indexed in Scilit:
- Genistein: the potential for efficacy in rheumatoid arthritisClinical Rheumatology, 2013
- A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative diseaseAnnals of the Rheumatic Diseases, 2012
- RETRACTED ARTICLE: Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progressionAngiogenesis, 2012
- Anti-angiogenic effects of genistein on synovium in a rat model of type Ⅱ collagen-induced arthritisJournal of Chinese Integrative Medicine, 2011
- (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 бvia Stat3 in gastric cancerWorld Journal of Gastroenterology, 2011
- Angiogenesis and its targeting in rheumatoid arthritisVascular Pharmacology, 2009
- Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia‐inducible factor‐1 and the down‐regulation of VEGF gene expressionCancer, 2003
- Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathwayOncogene, 2003
- Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasisOncogene, 2003
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002